Cryptopharma Pty Ltd

Novel Anti-Inflammatory Therapeutics

Cryptopharma is a startup company dedicated to developing therapeutic treatments for anti-tumour and anti-inflammatory indications.

Our initial developments have centred on analogues of 2-methoxyestradiol (2MEO), with a focus on asthma as the indication.

We have developed a family of compounds which are highly potent and selective inhibitors of smooth muscle cell proliferation, and which have demonstrated anti-asthmatic activity in in-vivo mouse models.

We believe that these compounds may represent a totally novel therapeutic approach to treating asthma.

Uniseed Investment Committee Project Manager: Dr Charles Day